Use the box below to search for a medication.

[add-search-inside]

FAA Accepted Medications Master List | Updated 9/26/24*
The following list of FAA-accepted medications is the most accurate and complete information available to our staff on the listed date. This “master list” was developed by Pilot Medical Solutions through our ongoing communication with the FAA. The FAA does not publish or certify an official list of approved drugs. This list may contain errors and omissions. Acceptable medications are typically approved only for the condition listed on a case by case basis. Some medications listed may not be approved for a given individual and medications not listed may also be acceptable to the FAA. SUBMIT A MEDICATION HERE

To assure FAA medical eligibility call 405-787-0303 for a free consultation.  

Acne – Most antibiotics such as Minocin (Minocyline) are acceptable to the FAA. Pilots should wait 48 hours after the initial dose to assure no adverse side effects occur.   Aldactone and CaroSpir (Spironolactone) are approved on a case by case basis. Accutane (Isotretinoin) may also be approved with the restriction “NOT VALID FOR NIGHT FLYING” on the medical. Other brands of Isotretinoin include: Absorica, Acitretin, Claravis, Isoface, Myorisan, Roaccutane, Soriatane, Sotret, Zenatane. To remove the restriction Isotretinoin must be permanently discontinued for at least 2 weeks prior to a comprehensive medical evaluation.

ADD – See Attention Deficit Disorder

Allergy, Antihistamine, Cold & Decongestants – Sudafed (Pseudoephedrine) is approved by the FAA provided there are no adverse effects and it is not combined with an anti-histamine.  Allegra (Fexofenadine), Astelin (Astepro & Azelastine), Dymista (Azelastine HCl / Fluticasone propionate), Claritin (Loratadine) and Clarinex (Desloratadine) are acceptable to the FAA provided no adverse effects are experienced.  Mucinex, Wal-Tussin, Chest Congestion Relief, Mucus Relief Chest, Scot-Tussin Expectorant, G-Fenesin, Child Mucus Relief Expectorant, Refenesen, Tussin Honey, Siltussin SA (Guaifenesin) may be acceptable provided the condition is not prohibitive or limiting and there are no adverse reactions. Vitamin B-12 or other prophylactic injections are approved provided there are no side effects. Sedating or psychotropic medications including but not limited to Atarax, Vistaril (Hydroxyzine) and Levocetirizine (Xyzal) are not acceptable. This includes but is not limited to Benadryl (Dipenhydramine), Meclizine (Antivert) and Zyrtec (Cetirazine).  MORE

Inhalers approved on a case-by-case basis:

  • Advair, Arnuity, Beser, Breo, Cutivate, Dymista, Flovent, Flonase, Trelegy, Veramyst, Wixela (Fluticasone Propionate)
  • Afrin (Oxymetazoline Hydrochloride)
  • Apovent, Atrovent, Ipraxa, Rinatec (Ipratropium)
  • Beconase (Beclomethasone Dipropionate)
  • Dulera (Mometasone Furoate & Formoterol Fumarate Dihydrate)
  • Flonase (See Fluticasone Propionate ABOVE)
  • Nasalcrom (Cromolyn Sodium)
  • Nasalide (Flunisolide)
  • Vancenase (Beclomethasone Dipropionate)
  • Venteze (Salbutamol / albuterol)

Anaphylaxis – Epinephrine auto-injectors (EpiPen’s) are used for emergency situations of allergic reaction or anaphylaxis. The FAA encourages pilots to carry their EpiPen if they have been prescribed one. Airman should not act as pilot in command following any use of an epinephrine auto-injector until all symptoms have subsided and they are examined and cleared by a physician to resume all activities. Allergies or conditions requiring Epinephrine may not be approved by the FAA.

Analgesics – Most medications in this class are not approved.  This includes but is not limited to: Suboxone, Buprenorphine, Methadone, Oxycodone, Tramadol, Fentanyl, Morphine, Hydrocodone, Buprenorphine, Metamizole / Dipyrone, Naloxone, Gabapentin, Hydromorphone, Codeine & Butorphanol.

Angina (Antianginal) cardiovascular related symptoms – Nitrate drugs such as Nitroglycerin, Nitrostat, Nitrolingual, Isosorbide dinitrate, Imdur, Rectiv, Nitro-Time, and Nitronal as well as Ranexa (Ranolazine) are not approved by the FAA.  Cases where these drugs have been prescribed post-operatively to build enhance blood vessel growth or as preventive “PRN / as needed” precautionary measure may be acceptable if they have not been utilized, or have been discontinued, provided favorable eloquent documentation is provided.

Ankylosing Spondylitis – See Anti-inflammatory

Antacids / G.I. Medications – The following medications are approved by the FAA on a case by case basis only. [Pilots With Ulcers]

  • Aciphex (Rabeprazole)
  • Asacol, Lialda (Mesalamine)
  • Axid (Nizatidine)
  • Azulfidine ((Sulfasalazine))
  • Cytotec (Misoprostol)
  • Dexilant (Dexlansoprazole)
  • Dipentum (Olsalazine)
  • Imodium (Loperamide) (LIMITED USE)
  • Mylanta (Magnesium hydroxide, Aluminum hydroxide, Simethicon)
  • Nexium (Esomeprazole)
  • Pepcid (Famotidine)
  • Prevacid (Lansoprazole)
  • Prilosec (Omeprazole)
  • Propulsid (Cisapride)
  • Protonix (Pantoprazole sodium)
  • Reglan (Metoclopramide hydrochloride)
  • Rolaids (Calcium Carbonate <550 mg>, Magnesium Hydroxide<110mg>)
  • Tagamet (Cimetidine)
  • Tums (Calcium Carbonate)
  • Zantac (Ranitidine)
  • Zelnorm (Tegaserod Maleate)

Anti-Bacterial – Flagyl (Metronidazole)

Antibiotics – The use of antibiotics is usually permissible on a case by case basis, provided the drug has been taken for long enough (usually 48 hours) to rule out the possibility of adverse effects.

A partial list of acceptable antibiotics include:

  • Azactam (Aztreonam)
  • Augmentin, Amoxil (Amoxicillin / Clavulanic Acid)
  • Biaxin (Clarithromycin)
  • Cipro (Ciprofloxacin)
  • Flagyl (Metronidazole) (case by case approval for bacteria & parasites)
  • Floxin (Ofloxicin)
  • Keflex, Panixine Disperdose (Cephalexin)
  • Levaquin (Levofloxacin)
  • Monodox (Doxycycline)
  • Zithromax (Azithromycin)

Anticholinergics (oral) Atropine and Cogentin (Benztropine) are not acceptable.

Anti-Coagulants – Xarelto (Rivaroxaban) may be considered after 2 weeks of documented stability on the medication. A current status report every 6 months is required for First and unrestricted Second-Class Medicals, every 12 months for Restricted Second- and Third-Class. The status report must include details of the underlying condition, how tolerating the medication and specific comments regarding any bleeding episodes requiring medical attention and any occurrence/recurrence of DVT/PE.

The following may be approved on a case by case basis:

  • Aspirin (Salicylate)
  • Brilinta (Ticagrelor) – SI only
  • Coumadin (Warfarin)
  • Effient (Prasugrel)
  • Eliquis (Apixaban)
  • Lovenox (Enoxaparin)
  • Plavix (Clopidrogrel)
  • Pletal (Cilostazol)
  • Trental (Pentoxifylline)

Anti-Depressants / Anxiety – Single-use Anti-Depressants such as: Celexa (Citalopram Hydrobromide), Lexapro (Escitalopram Oxalate), Prozac (Fluoxetine Hydrochloride), Zoloft (Sertraline Hydrochloride). Wellbutrin XL (Extended Release Bupropion) and Sustained Release (SR) are acceptable on a case by case basis while Immediate Release (IR) is not. – In addition, Khedezla & Pristiq (Desvenlafaxine), Cymbalta & Yentreve (Duloxetine), Vensir, Vencarm, Venlalix, Effexor & Venlablue (Venlafaxine) are also approved by the FAA for mild to moderate depression on a case by case basis. Doctor Northrup, the current Federal Air Surgeon, officially added Wellbutrin (as listed) to the potentially approvable antidepressants in 2023.  The latter listed medications were also approved by Dr. Northrup in 2024. Approval for any psychiatric drug is very strict and does not permit applicants to be approved by an AME or even the FAA office in Oklahoma City.  These cases are decided by the FAA office in Washington, D.C. and many cases are not approved for a variety of reasons. Contact us at 405-787-0303 to discuss eligibility criteria in detail.

All other SSRI’s or other psychiatric medications, including but not limited to: Xanax (Alprazolam), Klonopin (Clonazepam), Ativan (Lorazepam), Luvox (Fluvoxamine), Nortiriptyline (Pamelor), Norpramin (Desipramine), Paxil (Paroxetine), Valium, Diastat, Diastat & AcuDial (Diazepam), Viibryd (Vilazodone), Prudoxin (Doxepin), Silenor, Zonalon and Prudoxin are not acceptable to the FAA.

Some vitamins and herbal preparations such as Deplin (Levomefolic acid) or Saint Johns Wort may be utilized provided the condition being treated is not disqualifying.     MORE

Anti-Fungal – The following may be approved by the FAA on a case by case basis:

  • Diflucan (Fluconazol)
  • Griseofulvin (Fulvicin)
  • Gris-PEG (Griseofulvin)
  • Itraconazole (Sporanox)
  • Lamisil (Terbinafine)
  • Sporanox (Traconazole)

Anti-CGRP (Calcitonin Gene-Related Peptide) treatments – The following may be approved by the FAA on a case by case basis:

  • Aimovig (Erenumab)
  • Ajovy (Fremanezumab)
  • Emgality (Galcanezumab)

Anti-Histamine (Antihistamine) –  See Allergy, Cold & Decongestants

Anti-Inflammatory & Arthritis – The following medications are usually FAA approved provided there are no side effects and the condition being treated does not preclude safe performance of flight duties:

  • Acetaminophen
  • Advil (Ibuprofen)
  • Aleve (Naproxen Sodium)
  • Ansaid
  • Arava (Leflunomide)
  • Arthrotec (Diclofenac)
  • Asacol (Mesalamine)
  • Aspirin
  • Azasan (Azathioprine)
  • Azulfidine (Sulfasalazine)
  • Celebrex (Celecoxib)
  • Cataflam (Diclofenac Sodium)
  • Daypro (Oxaprozin)
  • Dolobid (Diflunisal)
  • Elmiron (Pentosan)
  • Enbrel (Etanercept)
  • Feldene (Piroxicam)
  • Ibuprofen
  • Imuran (Azothioprine)
  • Indocin (Indomethacin)
  • Lodine (Etodalac)
  • Meclofenamate (Meclofenamic Acid)
  • Mediprin
  • Methotrexate (not approved for cancer)
  • Mobic (Meloxicam)
  • Motrin (Ibuprofen)
  • MotrinIB (Ibuprofen)
  • Naprosyn (Naproxen Sodium)
  • Naproxen (Naproxen Sodium)
  • Orudis (Ketoprofen)
  • Oruvail (Ketoprofen)
  • Otezla (Apremilast)
  • Plaquenil – Requires eye evaluation
  • Purixan (Purinethol)
  • Relafen (Nabumetone)
  • Remicade (Infliximab)
  • Rheumatrex (Methotrexate, not approved for cancer)
  • Rinvoq (Upadacitinib)
  • Synvisc (Hylan G-F 20) Injections may be approved on a case by case basis
  • Tylenol (Acetaminophen)
  • Toradol (Ketorolac Tromethamine)
  • Trexall (Methotrexate not approved for cancer)
  • Voltaren (Diclofenac Sodium)
  • Xeljanz (Tofacitinib Citrate) [rheumatoid arthritis]

Anti-Malarial –  The following medications are acceptable for malaria prophylaxis:  A 24 hour “adverse effect” observation period should be observed prior to flight.

  • Chloroquine Phosphate
  • Malarone (Atovaquone + Proguanil HCL)

Anti-Neoplastic Agents – Purinethol (Marcaptopurine and Gleevec (Imatinib Mesylate) are considered for FAA medical certification on a case by case basis.

Antispasmodics – The use of antispasmodics for diarrhea, abdominal cramping, etc. are generally not acceptable.
Some examples of such medications are Bentyl (Dicyclomine), Levsin (hyoscyamine), Librax (Chlordiazepoxide and Clidinium), and Lomotil (diphenoxylate and atropine). The medication Imodium (loperamide) is acceptable on a case by case basis.

Antiplatelet -Aggrenox (Aspirin & extended-release Dipyridamole) is approved on a case by case basis.

Anti-Viral – The following medications are approved by the FAA on a case by case basis:

  • Famvir (Famciclovir)
  • Fludara (Fludarabine)
  • Hepsera (Adefovir Dipivoxil)
  • Rebetol, Virazole (Ribavirin)
  • Tamiflu (Oseltamivir)
  • Tenofovir (Disoproxil Fumarate)
  • Truvada (Emtricitabine / Tenofovir)
  • Valtrex (Valacyclovir)
  • Viread (Tenofovir Disoproxil Fumarate)
  • Zerit (Stavudine)
  • Zovirax (Acyclovir)

Arrhythmia (heart) – Some commonly prescribed drugs such as Tikosyn (Dofetilide) are not approved by the FAA.  The following anti-arrhythmic medications are approved on a case by case basis and subject to a complete cardiovascular evaluation.

  • Betapace (Sotalol)
  • Calan (Verapamil)
  • Cordarone, Pacerone (Amiodarone-up to 200 mg per day for A-Fib only)
  • Lanoxin (Digoxin)
  • Multaq (Dronedarone) Requires extensive cardiovascular work-up.
  • Norpace (Disopyramide)
  • Rythmol (Propafenone)
  • Tambocor (Flecainide Acetate) not allowed in cases of myocardial infarction or left ventricular dysfunction.
    MORE

Arthritis – See Anti-Inflammatory

Asthma / COPD – These conditions often require a combination of drugs which are usually approved by the FAA on an individual basis only.  Serevent (salmeterol xinafoate) and Wixela (Salmeterol) are not acceptable to the FAA. Prednisone may be acceptable up to 20 mg only. Hydrocortisone may be acceptable up to 80mg – 4mg of Hydrocortisone is equal to 1 mg of Prednisone. See “Steroids” for more information. Other case by case approved medications include but may not be limited to:

  • Advair, Flovent (Fluticasone Propiona)
  • Accolate (Zafirlukast)
  • Aerobid (Flunisolide)
  • Azmacort (Tiamcinolone)
  • Breo Ellipta (Fluticasone and Vilanterol)
  • Dulera (Mometasone Furoate & Formoterol Fumarate Dihydrate)
  • Dupixent (Dupilumab)
  • Foradil (Formoterol)
  • Proventil, Pentolin, Ventolin (Albuterol)
  • Serevent (Salmeterol)
  • Singulair (Montelukast)
  • Spiriva (Tiotropium Bromide)
  • Symbicort (Entocort, Uceris, Pulmicort, Rhinocort (budesonide – formoterol fumarate dihydrate)
  • Theo-Dur, Uniphyl (Theophylline)
  • Venteze (Salbutamol / Albuterol)
  • Xolair (Omalizumab)
  • Zyflo (Zileuton)    MORE

Attention Deficit (ADD) – [Concerta, Daytrana, Methylin, Ritalin (Methylphenidate)], [Adderall, Mydayis (Dextroamphetamine and Amphetamine)], [Dexedrine, Evekeo (Amphetamine)], Nuvigil (Armodafinil), Provigil (Modafinil), Focalin (Dexmethylphenidate), Quillivant XR (Methylphenidate), and Strattera (Atomoxetine) are not approved by the FAA.  Approval for ADD is more likely for adults due to the difficulty in accurately evaluating ADD in young people and all cases require at least 90 Days off medication prior to consideration.

Benign Prostatic Hypertrophy (BPH) – Sanctura & Sanctura XR (Trospium Chloride) are not acceptable. The following are approved by the FAA for the prevention or treatment of Benign Prostatic Hypertrophy (BPH) on a case by case basis:

  • Avodart (Dutasteride)
  • Cardura (Doxazosin Mesylate)
  • Dibenzyline (Phenoxybenzamine HCL)
  • Flomax (Tamsulosin HCL)
  • Hytrin (Terazosin HCL)
  • Minipress, Minizide (Prazosin HCL)
  • Proscar (Finasteride)
  • Rapaflo (Silodosin) (30-day wait)
  • Saw Palmetto
  • Uroxatral (Alfuzosin Hydrochloride)

Bi-Polar Disorder – With the exception of herbal preparations (Saint Johns Wort), psychotropic medications, such as lithium, are not approved by the FAA for Bi-Polar Disorder. When properly diagnosed, this condition is not approved by the FAA.   MORE

Bladder Control –  Ditropan (Oxybutynin Chloride), Enablex (Darifenacin), Detrol (Tolterodine Tartrate), Vesicare (Solifenacin Succinate) Sanctura XR & Sanctura (Trospium Chloride) and Toviaz (Fesoterodine Fumarate) are not acceptable to the FAA.  Myrbetriq (Mirabegron) may be approved by the FAA for bladder control after establishing no adverse effects.

Bladder Disorders – including Leukemia, Polycythemia Vera, and Thrombocytopenia. Hydroxyurea may be acceptable to the FAA on a case by case basis.

Blood Thinners – With the exception of aspirin, detailed information regarding the underlying condition and evidence of efficacious therapeutic effect is required for favorable FAA consideration. The following are approved on a case by case basis:

  • Aggrenox (Aspirin & Dipyridamole)
  • Aspirin (Salicylate)
  • Coumadin (Warfarin)
  • Lovenox (Enoxaparin)
  • Plavix (Clopidrogrel)
  • Pletal (Cilostazol)
  • Pradaxa (Dabigatran Etexilate Mesylate)
  • Trental (Pentoxifylline)
  • Xarelto (Rivaroxaban)

Blood Pressure (Hypertension) – Psychotropic or centrally acting agents such as Guanethidine, Guanadrel, Guanabenz, Intuniv/Tenex (Guanfacine), Methyldopa, Reserpine and Nitrates (ex. nitroglycerin/isosorbide dinitrate/isosorbide mononitrate) are not acceptable to the FAA. AME’s are not allowed to issue airmen using Catapres (Clonidine), however, in the past it has been approved by internal FAA physicians provided it was used without adverse effects and was reported on previous FAA exams.

The following medications are FAA approved on a case by case basis:

Alpha Blockers / Inhibitors

  • Cardura (Doxazosin)
  • Dibenzyline (Phenoxybenzamine)
  • Hytrin (Terazosin)
  • Micardis (Telmisartan)
  • Minipress, Minizide (Prazosin)

Beta Blockers

  • Blocadren, Timolide (Timolol)
  • Bystolic (Nebivolol)
  • Cartrol (Carteolol)
  • Cibenzyline (Phenoxybenzamine)
  • Coreg (Carvedilol)
  • Corgard, Corzide (Nadolol)
  • Inderal, Inderide, Innopran (Propranolol)
  • Kerlone (Betaxolol)
  • Levatol (Penbutolol)
  • Lopressor, Toprol (Metoprolol)
  • Normodyne, Trandate (Labetalol)
  • Sectral (Acebutolol)
  • Tenormin, Tenoretic (Atenolol)
  • Visken (Pindolol)
  • Zebeta, Ziac (Bisoprolol)

Calcium Channel Blockers

  • Azor (Amlodipine / Olmesartan Medoxomil)
  • Adalat, Procardia (Nifedipine)
  • Caduet (Amlodipine Besylate + Atorvastatin Calcium)
  • Cardizem, Dilacor, Tiazac (Diltiazem)
  • Cardene (Nicardipine)
  • Calan, Covera, Isoptin, Veralan, Tarka (Verapamil)
  • DynaCirc (Isradipine)
  • Norvasc, Lotrel (Amlodipine)
  • Plendil, Lexxel (Felodipine)
  • Posicor (Mibefradil)
  • Sular (Nisoldipine)

Angiotensin Converting Enzyme (ACE) Inhibitors

  • Aceon (Perindopril Erbumine)
  • Accupril (Quinapril)
  • Altace (Ramipril)
  • Capoten, Capozide (Captopril)
  • Lotensin (Benazepril)
  • Mavik (Trandolapril)
  • Monopril (Fosinopril)
  • Prinivil, Prinzide, Zestril, Zestoretic (Lisinopril)
  • Univasc, Unitrec (Moexipril)
  • Vasotec, Vaseretic (Enalapril)

Angiotensin II Receptor Antagonists / Angiotensin Receptor Blockers (ARBs)

  • Azor (Amlodipine / Olmesartan Medoxomil)
  • Atacand (Candesartan)
  • Avapro, Avalide (Irbesartan)
  • Benicar (Olmesartan Medoxomil)
  • Benicar HCT (Olmesartan Medoxomil + Hydrochlorothiazide)
  • Cozaar, Hyzaar (Losartan)
  • Diovan, Exforge (Valsartan)
  • Edarbi (Azilsartan)
  • Micardis (Telmisartan)

Diuretics

  • Aldactone, Aldactazide &
    CaroSpir (Spironolactone)
  • Bumex (Bumetanide)
  • Camadex, Demadex (Torsemide)
  • Chlorthalid, Hygroton and Thalitone (Chlorthalidone)
  • Diuril, Hydrochlorothiazide, HCTZ, Hydrodiuril, Oretic, Enduron (Thiazides)
  • Dyazide, Maxzide, Moduretic (Combinations)
  • Dyrenium (Triamterene)
  • Lasix (Furosemide)
  • Lozol (Indapamide)
  • Mykrox (Metolazone)
  • Thalitone (Chlorthalidone)
  • Zaroxolyn, Mykrox (Metolazone)

Vasodilators

  • Apresoline, Apresazide, Hydra-Zide (Hydralazine) is acceptable.

Botox – Botulinum Neurotoxin may be FAA approved on a case by case basis only for severe muscle cramps, cosmetic wrinkle treatments or diagnostic purposes.

Cancer – Most cancer treatment/medications, such as; Chemotherapy, must be completed prior to resuming flight duties.  Other treatments such as Tecentriq (Atezolizumab) may be disqualifying. Topical chemotherapy medications such as Adrucil, Carac, Efudex, Fluoroplex and Tolak may be acceptable on a case by case basis when used for pre-cancerous and cancerous skin growths such as actinic or solar keratosis or superficial basal cell treatment. The IV or pill form of this medication is a systemic chemotherapy agent (known as 5-Fluorouracil, 5-FU or Xeloda) which is disqualifying. Pilots using the drugs / treatments below may also be accepted by the FAA on a case by case basis:

  • Femara (Letrozole)
  • Nolvadex (Tamoxifen)
  • Casodex (Bicalutamide), Lupron & Eligard (Leuprolide Acetate), Zytiga (Abiraterone Acetate) and Zoladex (Goserelin) may be acceptable on a case by case basis such as “in remission” prostate Cancer.
  • Radioactive seed implantation may be FAA approved after radioactivity is sufficiently reduced and side effects are absent.    MORE

Cardiovascular – With the exception of chest-pain drugs (ISMO, IMDUR, ISORDIL), many cardiovascular medications are FAA approved. (see arrhythmia, blood pressure, blood thinners, cholesterol)

Cervical Dystonia – Botulinum Neurotoxin may be FAA approved on a case by case basis with extensive requirements and restrictions.

Cholesterol / Lipid Management – Most medications used in the treatment of hyperlipidemia or the management of cholesterol are approved by the FAA.
Some of the medications, such as Caduet, Lescol (Fluvastatin), Colestid (Colestipol) and Praulent (Alirocumab) may require no-fly / wait-time after use and detailed favorable documentation for FAA approval.
This includes but may not be limited to:

  • Caduet (Amlodipine Besylate + Atorvastatin Calcium)
  • Colestid (Colestipol)
  • Crestor (Rosuvastatin Calcium)
  • Lescol (Fluvastatin)
  • Lipitor (Atorvastatin)
  • Livalo (Pitavastatin)
  • Lopid (Gemfibrozil)
  • Mevacor (Lovastatin)
  • Niacin (Nicotinic Acid)
  • Praulent (Alirocumab)
  • Pravachol (Pravastatin)
  • Precose (Acarbose)
  • Questran, Cholestyramine, Locholest, Prevalite (Cholestyramine Resin)
  • Tricor (Fenofibrate)
  • Vytorin (Ezetimibe / Simvastatin)
  • WelChol (Colesevelam Hydrochloride)
  • Zetia (Ezetimibe)
  • Zocor (Simvastatin)

Congestive Heart Failure (CHF)

Any CHF case must be considered by the actual FAA vs an FAA designated AME. One treatment which may be acceptable to the FAA is Entresto (Sacubitril/Valsartan) a fixed-dose combination medication for use in heart failure – neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan.  The condition must be stable with sufficient ejection fraction and no adverse effects.

Chronic Myeloid Leukemia (CML) – Sprycel (Dasatinib) is approved by the FAA on a case by case basis.

Contraceptives – Almost always approved

ColdSee Allergy / Cold Medications

Cough – Benzonatate may be acceptable and has 36 hour wait period after each use. Also see Allergy / Cold Medications.

Crohn’s Disease – Naltrexone may be acceptable to the FAA provided it is not taken for addiction. Stelara (Ustekinumab) may be acceptable and requires 24 hour wait after each injection. The following may be approved by the FAA on a case by case basis:

  • Pentasa (Mesalamine)
  • Imuran (Azathioprine)
  • Purixan (Purinethol)
  • Remicade (infliximab)
  • Tysabri (Natalizumab)
  • Xeljanz (Tofacitinib)

Cystic Fibrosis  Trikafta (Elexacaftor, Tezacaftor & Ivacaftor) is acceptable on a case by case basis.

Depression – Celexa (Citalopram Hydrobromide), Lexapro (Escitalopram Oxalate), Prozac (Fluoxetine Hydrochloride) and Zoloft (Sertraline Hydrochloride) are approved for pilots by the FAA on a case by case basis only.  With the exception of the aforementioned SSRI’s and herbal preparations such as Saint Johns Wort, psychotropic medications are rarely approved by the FAA. MORE

Dermatological – Accutane is approved treatment of acne during daytime flight only. Soriatane (Acitretin) for psoriasis is not acceptable to the FAA. Dupixent (Dupilumab) is acceptable for Atopic Dermatitis. Most topical medications for acne or similar conditions may be approved by the FAA.  Submit your medication

Diabetes – Humulin, Lantus (Insulin) is approved on a case by case basis for Class 3 medical certification only.  Amylinomimetics, such as Symlin (pramlintide), are not acceptable. As of January 27, 2021 SGLT-2 Inhibitors are acceptable to the FAA on a case by case basis. This includes Invokana (Canagliflozin), Farxiga (Dapagliflozin), Jardiance (Empagliflozin), Steglatro (Ertugliflozin). While the FAA accepts several medications combinations and other restrictions apply. Contact Pilot Medical Solutions for more information. On a case by case basis, with proper documentation and in the absence of certain conflicting medications, many oral hypoglycemic medications are approved for all classes.  These include:

  • Actos (Pioglitazone)
  • Adlyxin (Lixisenatide)
  • Amaryl (Glimeperide)
  • Avandamet (Rosiglitazone Maleate + Metformin Hydrochloride)
  • Avandia (Rosiglitazone)
  • Bydureon (Exenatide)
  • Byetta (Exenatide) & Liraglutide (Victoza) A 30 day wait period is required if the airman is on any sulfonylurea class hypoglycemic drugs.  A 14 day wait period is required if other diabetes medications are used by the pilot.  A 2 hour wait period is required after each injection before flying.
  • Diabeta or Glynase (Glyburide)
  • Diabenase (Chlorpropamide)
  • Diamicron (Gliclazide)
  • Glucophage, Fortamet, Glutetza, Riomet (Metformin)
  • Glucotrol (Glipizide)
  • Januvia (Sitagliptin) A 14-60 day wait period is required.  The wait is determined by the use or combination of other medications.
  • Janumet (Sitagliptin & Metformin)
  • Jentadueto (Linagliptin and Metformin Hydrochloride)
  • Glucotrol (Glipizide)
  • Glyset (Miglitol) Observation Period Required
  • Nesina (Alogliptin)
  • Onglyza (Saxagliptin)
  • Orinase (Tolbutamide)
  • Ozempic, Rybelsus, Wegovy (Semaglutide)
  • Prandin (Repaglinide)
  • Precose (Acarbose)
  • Saxenda (Liraglutide)
  • Starlix (Nateglinide)
  • Tanzeum (Albiglutide)
  • Tolinase (Tolazamide)
  • Tradjenta (Linagliptin)
  • Trulicity (Dulaglutide) Not acceptable in combination with a meglitinide (repaglinide or Prandin; neteglinide or Starlix)
  • Victoza (Liraglutide)

Some of these medications are not FAA approved in combination with other medications. Contact Us for a free consultation

Diarrhea – While this condition is usually self-limiting, the following medications may be used for minor occurrences:

  • Imodium
  • Kaopectate
  • Lomotil (Diphenoxylate Hydrochloride)
  • Pepto-Bismol

Other medications require discontinuation at least 48 hours prior to flight.

Diet – See Weight Loss/Management

Diuretics

  • Aldactone, Aldactazide (Spironolactone)
  • Bumex (Bumetanide)
  • Camadex, Demadex (Torsemide)
  • Chlorthalid, Hygroton and Thalitone (Chlorthalidone)
  • Diuril, Hydrochlorothiazide, HCTZ, Hydrodiuril, Oretic, Enduron (Thiazides)
  • Dyazide, Maxzide, Moduretic (Combinations)
  • Dyrenium (Triamterene)
  • Inspra (Eplerenone)
  • Lasix (Furosemide)
  • Lozol (Indapamide)
  • Mykrox (Metolazone)
  • Thalitone (Chlorthalidone)
  • Zaroxolyn, Mykrox (Metolazone)

Dry Eyes – Xiidra (Lifitegrast) is approved by the FAA on a case by case basis. The first concern is the condition which may itself be disqualifying. Approval requires at least 24 hour before flying following the first dosage of Xiidra to verify no adverse effects. Non – prescription eye drops and Ocufen (Flurbiprofen) are acceptable on a case by case basis. Using Xiidra with basic artificial tears drops may be acceptable but eye drops may cause blurring or tearing after use and should not be instilled in flight.

Dry Mouth – See Xerostomia

DVT (Pulmonary Embolis Prevention) Stroke Prevention – Lovenox Sub-Q (Enoxaparin Sodium), Xarelto (Rivaroxaban) and the drugs listed under anti-coagulants, may be FAA approved on a case by case basis only.

Endometriosis – Luprin / Lupron (Leuprolide) may be FAA approved on a case by case basis.

Erectile Dysfunction (Impotence) – Cialis (Tadalafil) is acceptable if used 36 or more hrs before flight. Alprostadil (Caverject Impulse, Prostin VR Pediatric & Muse), Levitra (Vardenafil hydrochloride) and Viagra (Sildenafil Citrate) are approved by the FAA (acceptable to fly 6 hrs after use).   MORE

Essential Thrombocytosis – Anagrilide is FAA approved on a case by case basis.

Gall Bladder – Gall Stones – Actigall (Ursidiol) is FAA approved on a case by case basis.

Gastrointestinal (G.I.) Issues (GERD, Irritable Bowel Syndrome (IBS), Etc.  – Colofac (mebeverine hydrochloride), Librax (chlordiazepoxide hydrochloride) and similar preparations containing psychotropic drugs are not acceptable to the FAA.

The following medications are ACCEPTABLE on a case by case basis only:

  • Aciphex (Rabeprazole)
  • Actigall (Ursodiol)
  • Asacol, Lialda (Mesalamine)
  • Axid (Nizatidine)
  • Azulfidine (Sulfasalazine)
  • Cytotec (Misoprostol)
  • Dexilant (Dexlansoprazole)
  • Dipentum (Olsalazine)
  • Imodium (Loperamide) (LIMITED USE)
  • Mylanta (Magnesium hydroxide, Aluminum hydroxide, Simethicon)
  • Nexium (Esomeprazole)
  • Pepcid (Famotidine)
  • Prevacid (Lansoprazole)
  • Prilosec (Omeprazole)
  • Propulsid (Cisapride)
  • Protonix (Pantoprazole sodium)
  • Reglan (Metoclopramide hydrochloride)
  • Rolaids (Calcium Carbonate (<550 mg>, Magnesium Hydroxide<110mg>)
  • Tagamet (Cimetidine)
  • Tums (Calcium Carbonate)
  • Zantac (Ranitidine)
  • Zelnorm (Tegaserod maleate)

UNACCEPTABLE medications included but is not limited to:

  • Diphenoxylate (Lomotil).
  • Anticholinergics (Bentyl)
  • Levsin (L-hyoscyamine)
  • Librax (chlordiazepoxide and clidinium)
  • Opiates (Paregoric)

Gingivitis – Most mouthwash type medications, including prescriptions drugs such as Chlorhexidine Gluconate, are FAA approved.

Glaucoma – Most glaucoma medications are FAA approved after proper evaluation. This includes: Alphagan (Brimonidine Tartrate), Cosopt (Dorzolamide), Diamox & Diamox Sequels (Acetazolamide), Pilocar (Pilocarpine), Timoptic (Timolol Maleate), Travatan (Travoprost) and Xalatan (Latanoprost)  MORE

Gout – Krystexxa (Pegloticase Injection) is not acceptable to the FAA. With detailed evaluation the following medications are usually FAA approved:

  • Benemid (Probenecid)
  • Colbenemid (Colchicine)
  • Zyloprimare (Allopurinol)

Graves’ Disease – Provided applicant is euthyroid, the following medications may be FAA approved on a case by case basis only:

  • Tapazole (Methimazole)
  • Propylthiouracil

Hair Growth – The following are FAA approved on a case by case basis:

  • Propecia (Finisteride)
  • Procaine (Procaine hydrochloride)
  • Rogaine (Minoxidil)

Headaches – The following drugs are FAA approved on a case by case basis only:

  • Acetaminophen
  • Aimovig (Erenumab)
  • Advil (Ibuprofen)
  • Ajovy (Fremanezumab)
  • Aleve (Naproxen Sodium)
  • Ansaid
  • Aspirin
  • Beta-Blockers (when labeled & approved by the FDA for headache type)
  • Caffergot
  • Calcium-Channel Blockers
  • Emgality (Galcanezumab)
  • Ibuprofen
  • Imitrex
  • Innopran XL (Propranolol Hydrochloride)
  • Motrin (Ibuprofen)
  • MotrinIB (Ibuprofen)
  • Naprosyn (Naproxen Sodium)
  • Naproxen (Naproxen Sodium)
  • Sansert (Methysergide)
  • Tylenol (Acetaminophen)
  • Zomig

Hemorrhoids – Vasculera (Diosmiplex) is a formulated prescription medical food product and may be approved by the FAA on a case by case basis.

Heart – With the exception of angina (chest-pain) meds (ISMO, IMDUR, ISORDIL), most cardiovascular medications are approved on a case by case basis. Serevent (Salmeterol xinafoate) and Wixela (Salmeterol) are not acceptable to the FAA. MORE (see: arrhythmia, blood pressure, blood thinners, cholesterol)

Hepatitis C – Pegasys (Peginterferon alfa-2a), Rebetron (Ribavirin and Interferon alfa-2b), Roferon-A (Interferon alpha -2a), Roferon-A (Interferon alfa-2a, Recombinat) are NOT acceptable to the FAA.
Hepsera (Adefovir Dipivoxil) and Rebetol (Ribavirin) MAY be approved by the FAA on a case by case basis only.

Herbal – Most herbal preparations are approved by the FAA provided there are no side effects and the condition being treated is not disqualifying.  MORE

Herpes – The following medications are approved by the FAA on a case by case basis:

  • Famvir (Famciclovir)
  • Valtrex (Valacyclovir)
  • Zovirax (Acyclovir)

HIV – The following antiretroviral and other HIV medications may be FAA approved on an individual basis for HIV treatment if prescribed in compliance with the DHHS Panel recommendations regarding the Clinical Practices for the Treatment of HIV. Emtricitabine and Tenofovir Disoproxil Fumarate may be acceptable to the FAA for HIV prophylaxis / pre-exposure (PrEP).

Case by case approval may be obtained for:

  • Biktarvy ( Bictegravir + emtricitabine + tenofovir alafenamide )
  • Epivir (Lamivudine)
  • Fludara (Fludarabine)
  • Genvoya (Elvitegravir + Cobicistat + Emtricitabine + Tenofovir Alafenamide)
  • Hepsera (Adefovir Dipivoxil)
  • Rebetol, Virazole (Ribavirin)
  • Sustiva (Efavirenz)
  • Tenofovir (Disoproxil Fumarate)
  • Truvada (Emtricitabine / Tenofovir)
  • Vascepa (Icosapent Ethyl)
  • Viread (Tenofovir Disoproxil Fumarate)
  • Zerit (Stavudine)   MORE

Hormone Replacement – Teatment (Premarin / Estrogen) is approved by the FAA.

Hyperhidrosis (excessive sweating) – Several medications such as Robinul, Cuvposa, Seebri, Qbrexza (Glycopyrrolate / Glycopyrronium bromide) and Hytrin (Terazosin Hydrochloride) may be acceptable on a case by case basis.

Hypertension – See Blood Pressure

Hyperthyroidism – Provided applicant is euthyroid, the following medications may be approved on a case by case basis only:

  • Tapazole (Methimazole)
  • Propylthiouracil

Immunizations – SEE Vaccinations

Infection – The use of antibiotics is often permissible, providing the drug is has been FDA approved for at least one year and has been used long enough (usually 48 hours) to rule out the possibility of adverse effects.  A partial list of acceptable antibiotics include:

  • Azactam (Aztreonam)
  • Augmentin, Amoxil (Amoxicillin)
  • Biaxin (Clarithromycin)
  • Cipro (Ciprofloxacin)
  • Floxin (Ofloxicin)
  • Keflex (Cephalexin)
  • Monodox (Doxycycline)
  • Zithromax (Azithromycin)

Influenza Virus Infection –  The following meds are FAA approved on a case by case basis:

  • Relenza (Zanamivir)
  • Tamiflu (Oseltamivir)

Impotence – See Erectile Dysfunction

Immunosuppressants – Immune System Suppressants / Anti-Rejection Agents – The following may be acceptable to the FAA on a case by case basis:

  • Humira (Adalimumab)
  • Myfortic and CellCept (Mycophenolate Mofetil)
  • Neoral (Cyclosporine)
  • Ocrevus (Ocrelizumab)
  • Rapamune (Sirolimus) – Condition treated may be disqualifying
  • Tacrolimus (Prograf, Protopic, Astagraf XL, and Envarsus XR)
  • Taltz (Ixekizumab)

Insomnia – See Sleep

Infertility –   The following may be acceptable for treatment of infertility case by case basis:

  • Clomid (Clomiphene Citrate)
  • Proxeed (acetyl-L-carnitine HCl)

Irritable Bowel Syndrome (IBS) – See GI

Itching

Itching –   Atarax (Hydroxyzine) is not acceptable.

Kidney Stones / Renal Calculi – Alkalinizing and Cholelitholytic Agents, such as those below, are approved by the FAA on a case by case basis.

  • Actigall, Urso (Ursodial)
  • Oracit, Urocit-K 10, Urocit-K 5 & Bicitra (Sodium Citrate)
  • Cytra-K & Polycitra-K (Potassium Citrate)
  • Cytra-3 and Polycitra (Citric Acid)

LaxativeSee also GI – Docusate (Col-rite, Colace, Ex-Lax, Senokot S) may be acceptable on a case by case basis.

Leukemia  – Imbruvica (Ibrutinib) is not acceptable to the FAA. Sprycel (Dasatinib), Purinethol (Marcaptopurine and Gleevec (Imatinib Mesylate) may be approved by the FAA on a case by case.

Lipid Management – See Cholesterol

Low Testosterone–   While Clomophene may be acceptable to the FAA, using it to treat low testosterone is an off-label use and, as such, its use should be carefully depicted.  The FAA has removed Androxal (Enclomiphene) from the list of acceptable drugs. The following may be acceptable for treatment of low testosterone on a case by case basis:

  • Arimidex (Anastrozole)
  • Androgel (Testosterone)
  • Clomid (Clomiphene)

Meniere’s Disease – Dyrenium (Triamterene) is acceptable on a case by case basis only.

Migraine – Medications such as Topamax (Topiramate) are not acceptable to the FAA. Nurtec (Remegepant) is not acceptable for daily use but may be acceptable for occasional use with a three (3) day waiting period. The following drugs are accepted by the FAA on a case by case basis only and depending upon the manifestation and severity of your migraines:

  • Axert (Almotriptan Malate)
  • Beta-Blockers (when labeled & approved by the FDA for migraines)
  • Caffergot
  • Calcium-Channel Blockers
  • Imitrex
  • Innopran XL (Propranolol Hydrochloride)
  • Maxalt (Rizatripatan)
  • Sansert
  • Zomig (Zolmitriptan)

Mood Enhancing – With the exception of herbal preparations, mood ameliorating medications are not approved by the FAA.

Motility – Linzess (Linaclotide) may be acceptable after observation and absence of adverse condition or effects.

Motion Sickness – Antivert, Bonine, D-Vert, Dramamine, Driminate II, Meclicot, Medivert, Ru-Vert-M, Meni-D (Meclizine) along with Scopolamine (Hyoscine Hydrobromide, Scopolamine Hydrobromide, Transderm Scop), Promethazine (Phenergan) and Trimethobenzamide (Tigan)are not approved by the FAA for flight deck use.  Any use within 36 hours of flying is unacceptable to the FAA.  This medication may be acceptable on a case by case basis up to twice monthly. Chronic use is disqualifying. Ginger root is an acceptable treatment for the prevention of benign motion sickness.   MORE

Mouth Infection Prevention – Most mouthwash type medications, including prescriptions drugs such as Chlorhexidine Gluconate, are FAA approved.

Multiple Sclerosis –  Medications which are used primarily for used for symptomatic or advanced-stage multiple sclerosis, are generally not acceptable. The following are FAA approved on a case by case basis:

  • Aubagio (Teriflunomide)
  • Avonex (Interferon BETA-1a)
  • Betaseron (Interferon beta-1b)
  • Copaxone Subcutaneous (Glatiramer Acetate)
  • Gilenya, Novartis (Fingolimod)
  • Ocrevus (Ocrelizumab)
  • Plegridy – (Peginterferon beta-1a)
  • Rebif (Interferon Beta 1A)
  • Tecfidera (Dimethyl Fumarate)
  • Tysabri (Natalizumab)

Muscle Relaxant & Antispastic Agents – Most of the medications in this class are not acceptable to the FAA due to central nervous system effects.  This includes but is not limited to: Flexeril (Cyclobenzaprine), Gablofen, Kemstro and Lioresal (Baclofen)

Myasthenia Gravis – Mestinon (Pyridostigmine) and Soliris (Eculizumab) may be approved on a case by case basis.

NarcolepsySee Sleep

Nasal PolupsDupixent (Dupilumab) a Monoclonal Antibody – Anti-interleukin 4-Receptor Antibody is acceptable on a case by case basis.

Nausea Zofran (Ondansetron) is not acceptable for flight deck use. Contact Pilot Medical Solutions for alternatives.

Nerve Agent Poisoning (prevention) – Mestinon (Pyridostigmine) is acceptable for prophylactic nerve agent poising.

Neuropathy – Mentax (L-methylfolate) may be acceptable on a case by case basis.

Obesity – The following may be FAA approved after 30 days without negative side-effects and on a case by case basis:

  • Saxenda (Liraglutide)
  • Xenical (Orlistat)

Osteoarthritis – See Anti-Inflammatory & Arthritis

Osteoporosis – The following may be FAA approved on a case by case basis:

  • Evista (Raloxifen)
  • Forteo (Teriparatide)
  • Fosamax (Alendronate)
  • Prolia, Xgeva (Denosumab)
  • Zometa (Zoledronic Acid)

Pain Management – Typically centrally acting opioid narcotics such as Codeine, Actiq-Duragesic-Fentora (Fentanyl), Hysingla ER – Zohydro ER (Hydrocodone), Lorcet-Lortab- Norco-Vicodin (Hydrocodone & Acetaminophen), Cymbalta / Irenka (Duloxetine), Dilaudid-Exalgo (Hydromorphone), Demerol (Meperidine), Dolophine-Methadose (Methadone), Astramorph-Avinza-Kadian-MS Contin-Ora-Morph SR (Morphine), OxyContin-Oxecta-Roxicodone (Oxycodone), Percocet-Endocet-Roxicet (Oxycodone and Acetaminophen), Targiniq ER (Oxycodone and Naloxone) and Nucynta (Tapentodol) are not acceptable to the FAA for flight-deck use. Pilots temporarily using these medications must provide ample documentation to demonstrate that an addiction is not present and that the condition for which they were prescribed is now satisfactorily resolved and does not require ongoing use of these medications.

The following medications may be FAA approved for short-term pain management, or in some cases, long-term minor pain or inflammation, provided there are no side effects and the condition being treated does not preclude safe performance of flight duties:

  • Actron, Orudis, Oruvail (Ketoprofen)
  • Advil, Cramp End, Dolgesic, Excedrin IB, Genpril, Haltran, Ibren, Ibu, Ibuprin, Ibuprohm, Ibu-Tab, Medipren, Midol IB, Motrin, MotrinIB, Nuprin, Pamprin-IB, Q-Profen, Rufen, Trendar (Ibuprofen)
  • Aleve, Anaprox, Anaprox DS, EC-Naprosyn, Naprelan, Naprosyn (Naproxen)
  • Ansaid, Ocufen (Flurbiprofen)
  • Arthrotec, Cataflam, Dyloject, DermacinRx, Flector<patch>, Lexitral, Solaraze, Xrylix, Voltaren, Zipsor, Zorvolex (Diclofenac)
  • Celebrex (Celecoxib)
  • Indocin, Indocin SR, Tivorbex (Indomethacin)
  • Relafen (Nabumetone)
  • Tylenol

Botox (derivative of the botulism bacteria) may be approved on a case by case basis.

Parkinson’s Disease – Many drugs such as Requip (Ropinirole), Mirapex (Pramipexole Dihydrochloride), Azilect, Atapryl, Carbex, Eldepryl, Selpak (Selegiline Hydrochloride), Comtan (Entacapone), Parlodel (Bromocriptine), Symmetrel (Amantadine Hydrochloride), Tasmar (Tolcapone), Exelon (Rivastigmine) and Permax (Pergolide) are not acceptable to the FAA.

The following may be approved by the FAA on a case by case basis only: Atamet, Copaxone (Galtiramer Acetate), Sinemet, Entacapon and Rytary (Carbidopa + Levodopa).

Periodontitis – Most mouthwash type medications, including prescriptions drugs such as Chlorhexidine Gluconate, are FAA approved.

Polycythemia – Hydrea (Hydroxyurea) is approved by the FAA on a case by case basis.

Prolactinoma / Pituitary Disorders – Dostinex (Cabergoline) may be acceptable for treatment of pituitary disorders (prolactanoma).

Prostate – Xtandi (Enzalutamide) is not acceptable for flight-deck use. The following may be FAA approved for Prostate Cancer on a case by case basis:

  • Casodex (Bicalutamide)
  • Eligard, Lupron Depot (Leuprolide Acetate)
  • Zolodex (Goserelin)
  • Zytiga (Abiraterone Acetate)
  • Radioactive seed implantation

The following are approved by the FAA for the prevention or treatment of Benign Prostatic Hypertrophy (BPH) on a case by case basis:

  • Cardura (Doxazosin Mesylate)
  • Dibenzyline (Phenoxybenzamine HCL)
  • Flomax (Tamsulosin HCL)
  • Hytrin (Terazosin HCL)
  • Minipress, Minizide (Prazosin HCL)
  • Proscar (Finasteride)
  • Saw palmetto
  • Uroxatral (Alfuzosin hydrochloride)

Psoriasis – Otezla (Apremilast) may be acceptable on a case by case basis. (Also See Dermatological)

Psoriatic Arthritis – See Arthritis

Psychiatric – Single-use Anti-Depressants such as: Celexa (Citalopram Hydrobromide), Lexapro (Escitalopram Oxalate), Prozac (Fluoxetine Hydrochloride), Zoloft (Sertraline Hydrochloride). Wellbutrin XL (Extended Release Bupropion) and Sustained Release (SR) are acceptable on a case by case basis while the Immediate Release (IR) formulation is not. – In addition, Khedezla & Pristiq (Desvenlafaxine), Cymbalta & Yentreve (Duloxetine), Vensir, Vencarm, Venlalix, Efexor & Venlablue (Venlafaxine) are also approved by the FAA for mild to moderate depression on a case by case basis. Many other psychotropic medications are not approved by the FAA. Medications not approved include, but are not limited to: Abilify (Aripiprazole), Ativan (Lorazepam), Desyrel (Trazodone), Klonopin (Clonazepam), Valium (Diazepam), Viibryd (Vilazodone),  Paxil (Seroxat), Luvox (Fluvoxamine) and Xanax (Alprazolam).   MORE

Pulmonary Embolis PreventionSee DVT and Anticoagulants

Renal CalculiSee Kidney Stones

Restless Leg Syndrome – Commonly prescribed drugs such as Comtan (Entacapon), Mirapex (Ramipexole), Neurontin (Gabapentin) and Requip (Ropinirol) are not approved by the FAA. Some medications which are approved on a case by case basis to treat “other” conditions may also have a beneficial effect upon RLS.  Examples of medications which are approved for other medical conditions and may have a possible benefit are:

  • Atamet, Sinemet (Carbidopa and Levodopa)
  • Copaxone (Glatiramer Acetate)

Rheumatoid ArthritisSee Anti-inflammatory & Arthritis

Seizure – Anti-seizure medications such as Keppra (Levetiracetam), Lyrica (Pregabalin), Mysoline (Primidone), Seroquel (Quetiapine), Tegretol (Carbamazepine), Topamax (Topiramate), Trileptal, Vimpat, Zarontin are NOT FAA approved for pilots.   MORE

Sickle Cell Anemia – Droxia (Hydroxurea) may be FAA approved on a case by case basis.

Scleroderma, Peyronie’s Disease – Potaba (Aminobenzoate) may be acceptable on a case by case basis.

Skin – Cosmetic wrinkle treatments with Botox (Botulinum Neurotoxin) may be FAA approved on a case by case basis with restrictions.

Skin ACNESee ACNE

Sleep Issues & Disorders – Sleep prevention medications, such as Dalmane (Flurazepam), Provigil (Modafinil), Nuvigil (Armodafinil) are generally not approved by the FAA.

Medications which are often used for insomnia or to synchronize sleep habits or treat desynchronosis / jet-lag, such as Ambien (Zolpidem), Lunesta (Eszopiclone), Edluar / Intermezzo / Zolpimist (Zolpidem) or Lunesta (Eszopiclone), may be acceptable to the FAA on a case by case basis. Criteria for approval includes, but may not be limited to, “occasional vs chronic use”, and requires a lengthy waiting period after use before safety-related duties. These drugs are disqualifying if used chronically.

Generally, sleep aiding medications are NOT approved by the FAA. This includes but is not limited to:

  • Halcion (Triazolam)
  • Restoril (Temazepam)
  • Sonata (Zaleplon)

Over-the-counter medications such as Tylenol PM or Excedrin PM (Acetaminophen, Diphenhydramine Hydrochloride) may be acceptable for temporary insomnia with a satisfactory grounding period.  Melatonin may be approved for pilots without sleep disorders.   MORE

Smoking Cessation – Nicotine patches or gum is approved on an individual basis. Chantix (Varenicline) is also approved on a case by case basis.  Chantix (Varenicline) is initially grounding until applicant demonstrates no adverse side-effects at 72hrs post peak dosage.  Zyban (Bupropion hydrochloride) or other mood ameliorating drugs may be utilized to quit smoking but must be discontinued prior to FAA approval.   MORE CESSATION INFO

Steroids – Topical steroids may be approved for the treatment of minor dermatological conditions on a case by case basis. Prednisone and methylprednisone and other steroids must be utilized at a dosage which is less than a dosage equal to 20mg of Prednisone. Dosage Calculator

  • Cortef (Hydrocortisone  up to 80mg -4 mg of Hydrocortisone is equal to 1 mg of Prednisone)
  • Florinef (Fludrocortisone acetate)
  • Low doses (up to 20mg) of Prednisone

Stroke Prevention See DVT and Anticoagulants

Thrombocytopenia – Favorable FAA consideration requires extensive evaluation. IVIG (Intravenous Immunoglobulin) treatments have been approved on a case by case basis. In addition, the following medication has been acceptable to the FAA on a case by case basis:

  • Hydrea, Droxia (Hydroxyurea)
  • Promacta (Eltrombopaq)

Thyroid – Medications such as Levothyroxine (Brand names Euthyrox, Lynthroid, Synthroid, Tirosint, L-Thyroxine, Levoxyl, Levothroid, Unithroid, and Novothyrox) and Cytomel (Liothyronine), used to stabilize thyroid function are usually approved but only an individual basis.

Topical – Accutane is approved treatment of acne during daytime flight only. Most topical medications for acne or similar conditions may be approved by the FAA.

Tuberculosis –  The anti-infective agent Isoniazid (Laniazid, Nydrazid) is approved by the FAA on a case by case basis only.

Ulcer – The use of prophylactic medications for the peptic ulcer illnesses, such as antacids, H-2 blockers, and Sucralfate may be allowed, depending on the specific condition and severity.  Favorable FAA consideration requires extensive evaluation. Medications approved on a case by case basis include:

  • Aciphex (Rabeprazole)
  • Asacol (Mesalamine)
  • Axid (Nizatidine)
  • Azulfidine ((Sulfasalazine))
  • Cytotec (Misoprostol)
  • Dipentum (Olsalazine)
  • Mylanta
  • Pepcid (Famotidine)
  • Prevacid (Lansoprazole)
  • Prilosec (Omeprazole)
  • Propulsid
  • Protonix (Pantoprazole sodium)
  • Reglan (Metoclopramide hydrochloride)
  • Rolaids
  • Tagamet (Cimetidine)
  • Tums
  • Zantac (Ranitidine)

Ulcerative Colitis – The following are approved on a case by case basis only:

  • Asacol (Mesalamine)
  • Azulfidine (Sulfasalazine)
  • Canasa (Mesalamine)
  • Dipentum (Olsalazine)
  • Imuran (Azothioprine)
  • Lialda (Mesalamine)
  • Pentasa (Mesalamine)
  • Remicade (Infliximab)

Urinary Tract Infections (UTI) – Sulfamethoxazole (Bactrim, Sulfatrim, and Bactrim DS are acceptable on a case by case basis.

Uterine Bleeding / Fibroids – Luprin, Lupron (Leuprolide) may be FAA approved on a case by case basis.

Urinary Retention – Urecholine (Bethanechol Chloride) is not acceptable to the FAA. See also Bladder Control and Bladder Disorders.

Vaccinations – Prophylactic injections such as; immunizations or B-12 shots are usually approved provided there are no side effects. More on this including COVID-19.

Viral Infection – The following anti-viral medications are approved by the FAA on a case by case basis:

    • Famvir (Famciclovir)
    • Rebetron, Virazole (Ribavirin)
    • Valtrex (Valacyclovir)
    • Zovirax (Acyclovir)

Weight Loss / Management (Diet) – Dexfenfluramine (Redux), Fenfluramine (Pondimin), Phentermine (Adipex), Phendimetrazine (Bontril, Adipost, Anorex-SR, Appecon, Melfiat, Obezine, Phendiet, Plegine, Prelu-2, Statobex) are NOT acceptable to the FAA.

  • Saxenda (Liraglutide) is approved by the FAA on a case by case basis. Requires a wait-period along with several other requirements.

Xenical (Orlistat) – is approved after observation for adverse effects.  While some over-the-counter or herbal preparations are not regulated by the FAA, they may have a high incidence of adverse side effects.   MORE

Xerostomia (Dry Mouth) – Evoxac (cevimeline) is not approved.  Salagen (Pilocarpine Hydrochloride) may be FAA approved to promote saliva on a case by case basis.

*This list is not intended to replace the advice of your physician nor should it be considered as medical or legal advice.  This list may contain errors or omissions and may not be the most up-to-date information available.  Contact Pilot Medical Solutions for the most current information concerning FAA medication approval.

Federal Aviation Regulations (Part 61) require a person who holds a current medical certificate shall not act as pilot in command, or in any other capacity as a required pilot flight crew-member, while that person: “Knows or has reason to know of any medical condition that would make the person unable to meet the requirements for the medical certificate necessary for the pilot operation; or Is taking medication or receiving other treatment for a medical condition that results in the person being unable to meet the requirements for the medical certificate necessary for the pilot operation.” For operations that do not require a medical certificate, a person shall not act as pilot in command, or in any other capacity as a required pilot flight crew member, while that person knows or has reason to know of any medical condition that would make the person unable to operate the aircraft in a safe manner.

New medications usually require a 1-year review hold beginning on the date of FDA approval. This is to establish a side effect profile beyond the manufacturers published material and does not include herbal preparations or supplements. Submit your medication

Contact us at 1-800-699-4457 or by email here
to confidentially discuss your FAA medical issues.